134 related articles for article (PubMed ID: 21048428)
1. Extracellular matrix-derived peptides and myocardial repair.
Mihardja SS; Yu J; Lee RJ
Cell Adh Migr; 2011; 5(2):111-3. PubMed ID: 21048428
[TBL] [Abstract][Full Text] [Related]
2. Using extracellular matrix-derived peptides to alter the microenvironment for myocardial repair.
Mihardja SS; Lee RJ
Curr Vasc Pharmacol; 2012 May; 10(3):342-6. PubMed ID: 22239636
[TBL] [Abstract][Full Text] [Related]
3. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
[TBL] [Abstract][Full Text] [Related]
4. Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction.
Mihardja SS; Gao D; Sievers RE; Fang Q; Feng J; Wang J; Vanbrocklin HF; Larrick JW; Huang M; Dae M; Lee RJ
PLoS One; 2010 Apr; 5(4):e10384. PubMed ID: 20442783
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction.
Rufaihah AJ; Yasa IC; Ramanujam VS; Arularasu SC; Kofidis T; Guler MO; Tekinay AB
Acta Biomater; 2017 Aug; 58():102-112. PubMed ID: 28600129
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
[TBL] [Abstract][Full Text] [Related]
7. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
[TBL] [Abstract][Full Text] [Related]
8. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
Jugdutt BI; Jelani A; Palaniyappan A; Idikio H; Uweira RE; Menon V; Jugdutt CE
Circulation; 2010 Jul; 122(4):341-51. PubMed ID: 20625108
[TBL] [Abstract][Full Text] [Related]
9. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
10. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction.
Sanchez-Mas J; Lax A; Asensio-Lopez MC; Lencina M; Fernandez-Del Palacio MJ; Soriano-Filiu A; de Boer RA; Pascual-Figal DA
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):460-469. PubMed ID: 28718055
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
12. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
13. Decellularized neonatal cardiac extracellular matrix prevents widespread ventricular remodeling in adult mammals after myocardial infarction.
Wang Z; Long DW; Huang Y; Chen WCW; Kim K; Wang Y
Acta Biomater; 2019 Mar; 87():140-151. PubMed ID: 30710713
[TBL] [Abstract][Full Text] [Related]
14. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
[TBL] [Abstract][Full Text] [Related]
15. Post-infarct cardiac injury, protection and repair: roles of non-cardiomyocyte multicellular and acellular components.
Du X
Sci China Life Sci; 2018 Mar; 61(3):266-276. PubMed ID: 29388041
[TBL] [Abstract][Full Text] [Related]
16. VEGF nanoparticles repair the heart after myocardial infarction.
Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
[TBL] [Abstract][Full Text] [Related]
17. Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction.
Dasa SSK; Suzuki R; Gutknecht M; Brinton LT; Tian Y; Michaelsson E; Lindfors L; Klibanov AL; French BA; Kelly KA
J Control Release; 2015 Dec; 220(Pt A):556-567. PubMed ID: 26122651
[TBL] [Abstract][Full Text] [Related]
18. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
[TBL] [Abstract][Full Text] [Related]
19. Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction.
Taniyama Y; Katsuragi N; Sanada F; Azuma J; Iekushi K; Koibuchi N; Okayama K; Ikeda-Iwabu Y; Muratsu J; Otsu R; Rakugi H; Morishita R
Hypertension; 2016 Feb; 67(2):356-61. PubMed ID: 26644236
[TBL] [Abstract][Full Text] [Related]
20. Letter by Csont and Ferdinandy regarding article, "Biglycan is required for adaptive remodeling after myocardial infarction".
Csont T; Ferdinandy P
Circulation; 2008 Oct; 118(15):e521; author reply e522. PubMed ID: 18838570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
